surgery set News
-
Basic ENT Surgery Set
Otorhinolaryngology is the medical specialty that deals with conditions of the ear, nose, and throat (ENT). Surtex Instruments manufacture the diverse instruments of the basic ENT surgery set to provide the best tools for the commonest diagnostic and therapeutic procedures in otolaryngology. The set includes three figures of Mod. Vienna Nasal Speculum with different blade lengths to offer ...
-
ODS Medical Inc has rebranded as Reveal Surgical
As of November 2nd, ODS Medical, a Montreal-based AI medical technology startup, has rebranded as Reveal Surgical. Reveal Surgical helps surgeons see the unseen. Reveal’s technology can detect cancerous tissue that has been left behind using traditional imaging methods, combining an AI engine that provides real-time tissue characterization and intuitive optical probes that can be ...
-
BioLargo Assigned Federal and Military Supply System National Stock Number
Opens recurring sales channels for health care related products - Establishes working capital line of credit to support sales efforts - BioLargo, Inc. (OTCQB: BLGO) announced its subsidiary Odor-No-More, Inc. was assigned National Stock Numbers (NSNs) for multiple products by the Defense Logistics Information Service (DLIS), allowing the U.S. military, and federal and civil agencies, to ...
-
EDGe Surgical Granted U.S. Patent for Next-Generation Awl-in-One Tap
EDGe Surgical, Inc., a company focused on developing and manufacturing smart orthopedic and spine surgical instruments, announced today that its next-generation Awl-in-One Tap™ device has been granted patent 10,912,483 titled “Handheld devices for use in medical procedures” by the United States Patent and Trademark Office. Awl-in-One Tap is a single-use spinal surgery ...
-
Exsomed Corporation announces nationwide mobile training and cadaver lab program to further deliver cutting-edge education and training to surgeons
ExsoMed Corporation, a privately held U.S.-based medical device company providing surgeons with innovative solutions in hand surgery, announced today that it has launched its new Mobile Training and Cadaver Lab Program for convenient, on-site surgeon education and training of its innovative solutions in hand surgery. ExsoMed’s Mobile Training and Cadaver Lab Program was designed with the ...
-
Coming Soon – The next addition to the EMPOWR Platform
EMPOWR Acetabular™ is DJO’s modern, premium, intelligently designed acetabular system featuring advanced fixation technologies, efficient instrumentation, and a feature enabling future dual mobility offering.1 This system – combined with our femoral stem options which all have 12/14 robust micro-threaded trunnions – provides surgeons a comprehensive THA solution for all ...
-
Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent
SPECTRUM, the world’s largest single-device registry in ophthalmology, has completed enrollment. The announcement was made today by Ivantis Inc., a company dedicated to developing new and innovative solutions for glaucoma. SPECTRUM is a patient registry for the Hydrus® Microstent, a microinvasive glaucoma surgery (MIGS) device to treat patients with mild to moderate primary open-angle ...
-
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
A new case report published in the Journal of Vascular Surgery provides one of the first known opportunities to directly visualize the permanent and fused connection (anastomosis) that is created with the minimally invasive Ellipsys® Vascular Access System. The Ellipsys System, made by Avenu Medical, creates a type of dialysis access known as a percutaneous arteriovenous fistula (pAVF) for ...
-
EDGe Surgical Receives CE Mark Certification for EDG Ortho 65mm Electronic Depth Gauge
EDGe Surgical, Inc., a company focused on developing and manufacturing smart orthopedic and spine surgical instruments, announced today that it has received a CE Certificate of Conformity from its notified body permitting CE mark of the company’s EDG Ortho 65mm single-use electronic depth gauge in the European Union market. “This is a great achievement for EDGe Surgical on several ...
-
Neurent raises €9.3m to put paid to chronic runny noses
An Irish company developing a breakthrough therapy for a common nasal condition has raised €9.3 million. Neurent Medical, based in Oranmore, Co Galway, is developing a medical device that would allow doctors treat patients with rhinitis in their offices, rather than in a surgical setting. The funding round was led by Fountain Healthcare Partners, the Irish life sciences fund. Others ...
-
Gynesonics Announces First Office-Based Sonata Procedure in the State of Texas
Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the state of Texas to offer its Sonata® Treatment to women with symptomatic uterine fibroids as an office-based procedure at his River Place ...
By Gynesonics
-
Cerapedics Announces Publication of Results of Study Evaluating the Cost-Effectiveness of i-FACTOR vs. Local Autologous Bone in ACDF Surgery
Cerapedics Inc., a private ortho-biologics company dedicated to enhancing the science of bone repair, announced today that results of a study to evaluate the cost-effectiveness of i-FACTOR Peptide Enhanced Bone Graft compared to autograft for patients undergoing ACDF surgery were recently published in ClinicoEconomics and Outcomes Research (July 2021, Volume 2021, Issue 13). In this landmark ...
-
Centers for Medicare and Medicaid Services Issues Updated Payment Guidelines for Halifax Biomedical Services.
The Centers for Medicare & Medicaid Services (CMS) in the United States have issued an update to payment policies and payment rates for services furnished to Medicare beneficiaries in hospital outpatient departments and Ambulatory Surgical Centers (ASCs) beginning January 1, 2015. The following procedures codes that relate to HBI’s products and services were addressed in this payment ...
-
Optim Partners with MedShare to donate ENTity Endoscopes
Optim LLC, a premier manufacturer of proprietary flexible endoscopes for use in the visual diagnosis of Ear-Nose-and-Throat (“ENT”) disorders, announced today it has partnered with MedShare of Decatur, GA to donate the companies ENTity Nasopharyngoscopes to under-served communities around the globe. “The opportunity to give back to communities who do not have access to ...
By Optim LLC
-
Empirical Spine Submits PMA Module II for Limiflex as a New Motion-Preserving, Minimally Invasive Standard in Spine Surgery
Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, recently submitted Premarket Approval (PMA) Module II in the US Food & Drug Administration (FDA) approval process for its LimiFlex™ Dynamic Sagittal Tether™ (DST). LimiFlex is ...
-
Empirical Spine Closes $10 Million Series B Financing
Empirical Spine, Inc., maker of the LimiFlex Paraspinous Tension Band, today announced the closing of a Series B financing of $10 million. SHD (Scientific Health Development) led the round, with additional investment from GP&G (Green Park & Golf) and other syndicate members. The funds will be used to advance the product on its path to market, including completing the ongoing pivotal trial ...
-
First-Ever Four-Year MIGS Pivotal Trial Results Show Hydrus Microstent Significantly Reduces Need for Invasive Surgery and Subsequent Glaucoma Medication
Ivantis, Inc., developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients, announced today the first-ever, four-year follow-up data for a MIGS device in an FDA pivotal trial. The latest findings from the HORIZON study confirm the benefits of the Hydrus Microstent seen in earlier follow-up and ...
-
Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial
CONSHOHOCKEN, Pa. Mar. 19, 2019 --(BUSINESS WIRE)--Rex Medical, L.P., a medical device design and development company, today announced the successful completion of enrollment in the Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization (REVEAL) IDE clinical trial. The REVEAL trial is a single arm, prospective study to evaluate the safety ...
-
Two-year Ellipsys data featured at annual Controversies in Dialysis Access (CiDA) Meeting
A landmark two-year follow-up study on the Ellipsys® Vascular Access System was highlighted at the annual Controversies in Dialysis Access (CiDA) meeting, one of the premier dialysis access medical conferences in the world. The Ellipsys System from Avenu Medical is a non-surgical alternative to creating vascular access for end-stage renal disease (ESRD) patients who require hemodialysis. It ...
-
UroGen Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments
UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat specialty cancers and urologic diseases, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an overview of the Company’s recent developments. “2020 was a pivotal year for UroGen with the launch of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you